BDF Gestion Trims Stake in UnitedHealth Group Incorporated $UNH

Key Points

• BDF Gestion reduced its ownership in UnitedHealth Group by 39.1% in Q2, holding 20,703 shares after selling 13,267 shares.
• UnitedHealth Group reported an EPS of $4.08, missing analysts' expectations of $4.45, with a revenue of $111.62 billion for the quarter.
• The company announced a quarterly dividend of $2.21, resulting in an annualized dividend of $8.84 and a yield of 2.6%.

BDF Gestion lowered its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 39.1% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 20,703 shares of the healthcare conglomerate's stock after selling 13,267 shares during the quarter. UnitedHealth Group accounts for about 0.7% of BDF Gestion's portfolio, making the stock its 29th biggest position. BDF Gestion's holdings in UnitedHealth Group were worth $6,459,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in UNH. Bayforest Capital Ltd grew its position in UnitedHealth Group by 685.7% during the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock worth $29,000 after acquiring an additional 48 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd grew its position in shares of UnitedHealth Group by 416.7% in the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock valued at $32,000 after purchasing an additional 50 shares in the last quarter. Copia Wealth Management purchased a new position in UnitedHealth Group during the fourth quarter worth about $42,000. IAG Wealth Partners LLC bought a new stake in shares of UnitedHealth Group in the 1st quarter valued at about $42,000. Finally, Investment Management Corp VA ADV bought a new position in UnitedHealth Group during the 4th quarter valued at approximately $44,000. 87.86% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

UNH has been the topic of several recent analyst reports. Piper Sandler cut their target price on UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating on the stock in a research note on Wednesday, July 30th. Barclays boosted their target price on shares of UnitedHealth Group from $337.00 to $352.00 and gave the company an "overweight" rating in a research report on Thursday, September 4th. Sanford C. Bernstein increased their price target on shares of UnitedHealth Group from $337.00 to $379.00 and gave the company an "outperform" rating in a research note on Friday, September 5th. Cantor Fitzgerald restated an "overweight" rating and issued a $440.00 price objective on shares of UnitedHealth Group in a report on Tuesday, August 26th. Finally, Wells Fargo & Company dropped their price target on shares of UnitedHealth Group from $306.00 to $267.00 and set an "overweight" rating on the stock in a research note on Monday, August 4th. Sixteen investment analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $358.95.

UnitedHealth Group Stock Up 0.6%

Shares of UNH stock traded up $1.90 during trading on Friday, hitting $336.72. 13,528,738 shares of the company were exchanged, compared to its average volume of 13,684,542. The firm has a market capitalization of $304.96 billion, a price-to-earnings ratio of 14.59, a P/E/G ratio of 2.20 and a beta of 0.44. The business's 50-day simple moving average is $295.67 and its 200 day simple moving average is $364.42. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm's quarterly revenue was up 12.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be issued a $2.21 dividend. The ex-dividend date is Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.6%. UnitedHealth Group's payout ratio is presently 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.